成大生物：2025年度业绩快报公告

Group 1 - The company, Chengda Biology, announced a projected total operating revenue of 1,390.29 million yuan for 2025, representing a year-on-year decline of 17.06% [2] - The net profit attributable to the parent company's shareholders is expected to be 137.62 million yuan, reflecting a significant year-on-year decrease of 59.86% [2]